Last Updated: June 12, 2026

MIDODRINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Midodrine patents expire, and when can generic versions of Midodrine launch?

Midodrine is a drug marketed by Alembic, Apotex, Aurobindo Pharma Ltd, Chartwell Rx, Impax Pharms, Mankind Pharma, Mylan Pharms Inc, Novugen, Ph Health, Rubicon Research, Unique, Xiromed, and Zydus Lifesciences. and is included in thirteen NDAs.

The generic ingredient in MIDODRINE is midodrine hydrochloride. There are thirteen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the midodrine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Midodrine

A generic version of MIDODRINE was approved as midodrine hydrochloride by MYLAN PHARMS INC on September 10th, 2003.

  Start Trial

AI Deep Research
Ask!
Questions you can ask:
  • What is the 5 year forecast for MIDODRINE?
  • What are the global sales for MIDODRINE?
  • What is Average Wholesale Price for MIDODRINE?
Summary for MIDODRINE
US Patents:0
Applicants:13
NDAs:13
Drug Prices: Drug price information for MIDODRINE
DailyMed Link:MIDODRINE at DailyMed
Drug patent expirations by year for MIDODRINE
Drug Prices for MIDODRINE

See drug prices for MIDODRINE

US Patents and Regulatory Information for MIDODRINE

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Unique MIDODRINE HYDROCHLORIDE midodrine hydrochloride TABLET;ORAL 207613-002 Nov 2, 2018 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Rubicon Research MIDODRINE HYDROCHLORIDE midodrine hydrochloride TABLET;ORAL 212543-001 Aug 19, 2019 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Unique MIDODRINE HYDROCHLORIDE midodrine hydrochloride TABLET;ORAL 207613-003 Nov 2, 2018 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Rubicon Research MIDODRINE HYDROCHLORIDE midodrine hydrochloride TABLET;ORAL 212543-002 Aug 19, 2019 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Alembic MIDODRINE HYDROCHLORIDE midodrine hydrochloride TABLET;ORAL 214734-001 Jan 21, 2021 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Mankind Pharma MIDODRINE HYDROCHLORIDE midodrine hydrochloride TABLET;ORAL 217271-003 Nov 1, 2023 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Novugen MIDODRINE HYDROCHLORIDE midodrine hydrochloride TABLET;ORAL 211973-003 Oct 17, 2023 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or Start Trial

DrugChatter Q&A for MIDODRINE
What are the side effects of Midodrine?

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links